Earnings · China A-shares
Zhejiang Starry Pharmaceutical Co., Ltd. Class A (603520) earnings
Zhejiang Starry Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +56.73% year on year, -31.00% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved +2.19% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +56.73%
- Excl. one-offs YoY
- -31.00%
- Net profit QoQ
- -72.34%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.96% | — |
| 3 days | +2.19% | — |
| 7 days | +6.44% | — |
| 14 days | -0.39% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +1.76%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥45.18M | +56.73% | -31.00% | +8.85% | 0.10 | 1.78% | +2.19% | — | — |
| 2026 interim report | 2026-08-31 | ¥39.93M | +37.05% | -48.53% | +1.18% | 0.09 | 1.55% | -2.10% | -10.97% | -1.64% |
| 2026 Q1 report | 2026-04-30 | ¥20.95M | +46.08% | +50.94% | +3.70% | 0.05 | 0.82% | +1.76% | -21.34% | -23.40% |
| 2025 annual report | 2026-04-30 | ¥10.23M | +120.83% | +105.20% | +4.07% | 0.02 | 0.39% | +1.76% | -21.34% | -23.40% |
| 2025 Q3 report | 2025-10-31 | ¥28.82M | +221.14% | +531.19% | +2.24% | 0.07 | 1.10% | -2.85% | -12.50% | -7.81% |
| 2025 interim report | 2025-08-29 | ¥29.14M | +27.24% | +34.28% | +5.06% | 0.07 | 1.11% | +5.66% | -5.22% | -6.49% |
| 2025 Q1 report | 2025-04-30 | ¥14.34M | +16.79% | +13.63% | +6.79% | 0.03 | 0.54% | +5.91% | +22.29% | +19.11% |
| 2024 annual report | 2025-04-30 | -¥49.10M | -211.00% | — | +7.02% | -0.12 | -2.16% | +5.91% | +22.29% | +19.11% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.